Tang Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Tang Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$58.6M	Hold	707,500	–	–	2.66%	15
2026 Q1	$54.4M	Buy	707,500 +226,063	+47%	+$17.6M	2.76%	16
2025 Q4	$38M	Buy	481,437 +163,937	+52%	+$14.2M	1.88%	17
2025 Q3	$29.1M	Hold	317,500	–	–	1.12%	26
2025 Q2	$20.7M	Hold	317,500	–	–	1.05%	26
2025 Q1	$21.3M	Hold	317,500	–	–	1.18%	21
2024 Q4	$17.6M	Sell	317,500 -132,500	-29%	-$7.61M	1.16%	22
2024 Q3	$26.8M	Hold	450,000	–	–	1.92%	11
2024 Q2	$28.7M	Buy	450,000 +300,000	+200%	+$19.5M	2.92%	6
2024 Q1	$10.4M	Buy	+150,000	New	+$9.06M	1.08%	30
2022 Q4	–	Sell	-100,000	Closed	-$3.21M	–	92
2022 Q3	$3.21M	Hold	100,000	–	–	0.39%	58
2022 Q2	$2.97M	Hold	100,000	–	–	0.45%	43
2022 Q1	$2.81M	Sell	100,000 -200,000	-67%	-$7.46M	0.56%	42
2021 Q4	$13.8M	Buy	+300,000	New	+$12.9M	2.78%	9

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Tang Capital Management's ANIP Position: Q2 2026 in Review

Tang Capital Management held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 707,500 shares worth $58.6M. The position accounts for 2.66% of the portfolio, ranked #15.

Tang Capital Management first reported a position in ANIP in Q4 2021 and has held it in 14 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

Tang Capital Management held 707,500 shares of ANI Pharmaceuticals worth $58.6M as of Q2 2026.
Tang Capital Management left its ANI Pharmaceuticals share count unchanged in Q2 2026.
ANI Pharmaceuticals made up 2.66% of Tang Capital Management's portfolio in Q2 2026, its #15 holding.
Tang Capital Management first reported a position in ANI Pharmaceuticals in Q4 2021 and has held it in 14 quarters since.
307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Tang Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.